Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
DEPT OF DEFENSE
This opportunity closed June 29, 2026. 5 similar opportunities are open right now.
Similar opportunities open now
- SWITCH,RADIO FREQUEOpenDEPT OF DEFENSECloses in 62 days
- 61--POWER SUPPLY - AND OTHER REPLACEMENT PARTSOpenDEPT OF DEFENSECloses today
- HEAT EXCHANGER,FLUIOpenDEPT OF DEFENSECloses in 6 days
- COVER,PRESS SEALOpenDEPT OF DEFENSECloses in 10 days
- COVER,PRESS SEALOpenDEPT OF DEFENSE.DEPT OF THE NAVY.NAVSUP.NAVSUP WEAPON SYSTEMS SUPPORT.NAVSUP WSS MECHANICSBURG.NAVSUP WEAPON SYSTEMS SUPPORT MECHCloses in 10 days
About this archived opportunity
The Department of War (DoW) is required by law (10 U.S.C. � 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ. P&T COMMITTEE MEETING: The following August 2026 drug classes/subclasses will be reviewed: a. ADHD Agents � Stimulants AZSTARYS COTEMPLA XR-ODT DYANAVEL XR JORNAY PM MYDAYIS QUILLICHEW ER QUILLIVANT XR XELSTRYM b. Oncological Agents - BRAF-MEK Inhibitors BRAFTOVI COTELLIC MEKINIST MEKTOVI TAFINLAR ZELBORAF The RFQ, including UF BPA and UF ADP appendices are attached here in. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-26-Q-9301. Pre-quotation teleconference is on May 13, 2026. Details are stated in Part 2.4. Pre-Quotation Teleconference.
Historical details
- Status
- Closed
- Deadline
- June 29, 2026
- First captured
- May 8, 2026
- Publisher reference
- 38fb9a33978f4e67b037c64798e35732
Eligibility: No Set aside used. NONE
This opportunity has closed
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
by DEPT OF DEFENSE
Get notified when similar opportunities open
We'll save this search and email you when new pharmacy, uniform, formulary opportunities are posted. Free.
Related opportunities
- SWITCH,RADIO FREQUEDEPT OF DEFENSECloses in 62 days
- 61--POWER SUPPLY - AND OTHER REPLACEMENT PARTSDEPT OF DEFENSECloses today
- 61--POWER SUPPLY - AND OTHER REPLACEMENT PARTSDEPT OF DEFENSECloses in 11 days
- HEAT EXCHANGER,FLUIDEPT OF DEFENSECloses in 6 days
- COVER,PRESS SEALDEPT OF DEFENSECloses in 10 days